Annual review of cytokines in cancer management. Summaries of selected studies of darbepoetin alfa, pegfilgrastim, palifermin, and other cytokines presented at six major meetings held in 2004.
D000068256:Darbepoetin alfa; D004921:Erythropoietin / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D051523:Fibroblast Growth Factor 7; D005346:Fibroblast Growth Factors / Q000627:therapeutic use*; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000276:immunology*; D009503:Neutropenia / Q000188:drug therapy*; D011092:Polyethylene Glycols; D011994:Recombinant Proteins
C496453:FGF7 protein, human; D011994:Recombinant Proteins; D004921:Erythropoietin; D051523:Fibroblast Growth Factor 7; D016179:Granulocyte Colony-Stimulating Factor; D000068256:Darbepoetin alfa; C455861:pegfilgrastim; D011092:Polyethylene Glycols; D005346:Fibroblast Growth Factors; D000069585:Filgrastim